DH Ergotoxin (Spofa) sublingual tablets in the treatment of cerebrovascular insufficiency in involution: clinical and experimental psychologic study.
D000368:Aged; D002561:Cerebrovascular Disorders / Q000150:complications*; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy* / Q000209:etiology; D010919:Placebos; D013607:Tablets
D010919:Placebos; D013607:Tablets; D004088:Dihydroergotoxine